170.90
Overview
News
Price History
Option Chain
Financials
Why MS Down?
Discussions
Forecast
Stock Split
Dividend History
Morgan Stanley stock is traded at $170.90, with a volume of 2.13M.
It is up +1.03% in the last 24 hours and up +4.39% over the past month.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
See More
Previous Close:
$169.09
Open:
$168.55
24h Volume:
2.13M
Relative Volume:
0.38
Market Cap:
$271.61B
Revenue:
$113.10B
Net Income/Loss:
$16.33B
P/E Ratio:
17.54
EPS:
9.7425
Net Cash Flow:
$10.35B
1W Performance:
+1.73%
1M Performance:
+4.39%
6M Performance:
+32.76%
1Y Performance:
+30.97%
Morgan Stanley Stock (MS) Company Profile
Name
Morgan Stanley
Sector
Industry
Phone
212-761-4000
Address
1585 BROADWAY, NEW YORK, NY
Compare MS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MS
Morgan Stanley
|
170.90 | 268.74B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
829.55 | 244.50B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
93.03 | 163.60B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
131.59 | 113.25B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
IBKR
Interactive Brokers Group Inc
|
64.65 | 28.32B | 10.17B | 4.13B | 33.07B | 2.0767 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-03-25 | Initiated | BMO Capital Markets | Outperform |
| Jul-09-25 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-15-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-24 | Downgrade | Goldman | Buy → Neutral |
| Aug-02-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-17-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-17-24 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Nov-20-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Oct-23-23 | Downgrade | Odeon | Buy → Hold |
| Oct-20-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Oct-11-23 | Downgrade | UBS | Buy → Neutral |
| Sep-07-23 | Initiated | HSBC Securities | Buy |
| Jul-12-23 | Upgrade | Odeon | Hold → Buy |
| Jan-18-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-10-23 | Upgrade | Odeon | Sell → Hold |
| Jan-04-23 | Downgrade | Wolfe Research | Outperform → Underperform |
| Oct-05-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-06-22 | Downgrade | Odeon | Hold → Sell |
| May-03-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-22 | Downgrade | Odeon | Buy → Hold |
| Dec-03-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-04-21 | Reiterated | Jefferies | Buy |
| Sep-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-28-21 | Downgrade | Berenberg | Buy → Hold |
| Aug-13-21 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-09-21 | Initiated | Jefferies | Buy |
| Apr-21-21 | Upgrade | Berenberg | Hold → Buy |
| Mar-02-21 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-06-21 | Initiated | Daiwa Securities | Neutral |
| Jan-04-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-10-20 | Downgrade | Citigroup | Buy → Neutral |
| Oct-13-20 | Resumed | JP Morgan | Overweight |
| Jul-08-20 | Initiated | Seaport Global Securities | Buy |
| Jun-24-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-23-20 | Reiterated | UBS | Buy |
| May-21-20 | Upgrade | Odeon | Hold → Buy |
| Apr-14-20 | Upgrade | Societe Generale | Sell → Buy |
| Mar-13-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-04-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-21-20 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-20-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-21-20 | Downgrade | Citigroup | Buy → Neutral |
| Jan-17-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-13-20 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-09-20 | Initiated | DA Davidson | Buy |
| Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-29-19 | Downgrade | Odeon | Buy → Hold |
| Oct-10-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jul-12-19 | Upgrade | Citigroup | Neutral → Buy |
| Apr-18-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Morgan Stanley Stock (MS) Latest News
Gitlab's Fiscal Q3 Revenue Beat Skimmed By Government Shutdown, Morgan Stanley Says - MarketScreener
REGN: Morgan Stanley Downgrades Regeneron Pharmaceuticals Rating to Equal-Weight | REGN Stock News - GuruFocus
Morgan Stanley’s China survey shows ’high’ willingness to adopt humanoids - Investing.com
Regeneron Shares Now Reflect Valuation as Pipeline Visibility Becomes Key, Morgan Stanley Says - MarketScreener
Energy Transfer LP price target lowered to $19 from $21 at Morgan Stanley - The Globe and Mail
Brookfield Infrastructure price target raised to $53 from $50 at Morgan Stanley - Yahoo Finance
South Bow price target raised to C$35 from C$34 at Morgan Stanley - Yahoo Finance
Douglas County senior living facility sells for $106M to banking giant - The Business Journals
Morgan Stanley Shares Surge 34.5% YTD: Buy Now or Wait? - Yahoo Finance Singapore
Morgan Stanley Reaffirms Equal Weight Rating for Michelin (OTCMKTS:MGDDY) - MarketBeat
Mettler-Toledo International (NYSE:MTD) Earns Equal Weight Rating from Analysts at Morgan Stanley - MarketBeat
Delta Air Lines Discusses Demand at Morgan Stanley Conference - TipRanks
KEI Industries Schedules Investor Meeting with Morgan Stanley - TipRanks
Morgan Stanley Lowers Price Target on Gitlab to $55 From $60, Keeps Overweight Rating - MarketScreener
Morgan Stanley Raises Price Target on Marvell Technology to $112 From $86, Keeps Equalweight Rating - MarketScreener
Energizer Holdings Discusses Strategy at Morgan Stanley Conference - TipRanks
Energizer Holdings, Inc. Participates in Morgan Stanley Conference - TradingView
Morgan Stanley lowers Okta stock price target to $110 from $123 - Investing.com India
Enel downgraded, E.ON lifted at Morgan Stanley in sector reshuffle - Investing.com
Here's Why We Think Morgan Stanley (NYSE:MS) Is Well Worth Watching - Yahoo Finance
Celsius Holdings Highlights 2025 Execution Progress Ahead of Morgan Stanley Global Consumer & Retail Conference - Yahoo Finance
Novartis, Bayer raised to Overweight by Morgan Stanley on valuation appeal - Investing.com
Morgan Stanley Downgrades Regeneron Pharmaceuticals to Equalweight From Overweight, PT is $767 - MarketScreener
Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential - Investing.com
Morgan Stanley Initiates Agilent Technologies at Overweight With $180 Price Target - MarketScreener
Morgan Stanley Upgrades Vertex Pharmaceuticals to Overweight From Equalweight, Adjusts PT to $516 From $438 - MarketScreener
3 Morgan Stanley Mutual Funds to Buy for Long-Term Returns - Zacks Investment Research
Morgan Stanley sees upside to European utilities - TradingView
Morgan Stanley initiates Medy-Tox stock with Equalweight rating - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities By Investing.com - Investing.com Australia
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Bausch + Lomb (BLCO) Is Up 7.3% After Morgan Stanley Highlights Disruptive Ophthalmology Pipeline - simplywall.st
Morgan Stanley downgrades Regeneron stock to Equalweight on balanced risk/reward - Investing.com India
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
US lifts China sentiment, but tensions cloud outlook in Japan: report - South China Morning Post
AstraZeneca stock price target raised to GBP155 by Morgan Stanley - Investing.com
E.ON stock rating upgraded by Morgan Stanley on attractive entry point - Investing.com
Bayer back towards previous day's highMorgan Stanley recommends - MarketScreener
Morgan Stanley Raises Target Price for Ørsted to 145 Danish Kroner, Maintains Equal Weight Rating - MarketScreener
Morgan Stanley Says Mortgage Aid May Halt China’s Housing Slump - Bloomberg.com
AWS Trainium 4 presents new Astera Labs opportunities, says Morgan Stanley - TipRanks
Why Morgan Stanley just got more bullish on Nvidia stock, even as it struggles - Yahoo Finance UK
Transcript : Warby Parker Inc. Presents at Morgan Stanley Global Consumer & Retail Conference 2025, Dec-02-2025 03 - MarketScreener
AI Data Center Opportunities Underpin Morgan Stanley's Bullish Stance On This Stock - Investor's Business Daily
AI Sparks New Economics for Electricity - Morgan Stanley
Solaris Energy started Overweight at Morgan Stanley as pricing reflects only limited growth - MSN
As Morgan Stanley Rises to Our Price Target, We're Watching the IPO Market - TheStreet Pro
Lam Research (LRCX) Jumps on Morgan Stanley Upgrade: Is the AI Wafer-Equipment Rally Running Hot or Just Getting Started? - ts2.tech
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC - StreetInsider
Morgan Stanley upgrades Tempus AI to “overweight” - Sherwood News
Morgan Stanley Stock (MS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):